GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » Equity-to-Asset

Pharmarise Holdings (TSE:2796) Equity-to-Asset : 0.30 (As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Pharmarise Holdings's Total Stockholders Equity for the quarter that ended in Feb. 2024 was 円7,872 Mil. Pharmarise Holdings's Total Assets for the quarter that ended in Feb. 2024 was 円26,425 Mil. Therefore, Pharmarise Holdings's Equity to Asset Ratio for the quarter that ended in Feb. 2024 was 0.30.

The historical rank and industry rank for Pharmarise Holdings's Equity-to-Asset or its related term are showing as below:

TSE:2796' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21   Med: 0.23   Max: 0.36
Current: 0.3

During the past 13 years, the highest Equity to Asset Ratio of Pharmarise Holdings was 0.36. The lowest was 0.21. And the median was 0.23.

TSE:2796's Equity-to-Asset is ranked worse than
68.19% of 679 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs TSE:2796: 0.30

Pharmarise Holdings Equity-to-Asset Historical Data

The historical data trend for Pharmarise Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings Equity-to-Asset Chart

Pharmarise Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.23 0.25 0.28 0.29

Pharmarise Holdings Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.29 0.29 0.36 0.30

Competitive Comparison of Pharmarise Holdings's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmarise Holdings's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's Equity-to-Asset falls into.



Pharmarise Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Pharmarise Holdings's Equity to Asset Ratio for the fiscal year that ended in May. 2023 is calculated as

Equity to Asset (A: May. 2023 )=Total Stockholders Equity/Total Assets
=6881/23421
=0.29

Pharmarise Holdings's Equity to Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

Equity to Asset (Q: Feb. 2024 )=Total Stockholders Equity/Total Assets
=7872/26425
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmarise Holdings  (TSE:2796) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Pharmarise Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmarise Holdings (TSE:2796) Business Description

Traded in Other Exchanges
N/A
Address
8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings (TSE:2796) Headlines

No Headlines